Projected savings from biosimilar natalizumab were $452,611 over 3 years, driven by decreased drug acquisition costs and a utilization shift from reference to biosimilar natalizumab. Objectives: ...

Managing system risk is paramount for organizations to protect their data and ensure operational continuity. Security Impact Analysis (SIA) is a critical component of this process, offering a ...